Brian Wood

Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer

Guru Sonpavde, John M. Burke, J. R. Caton et al. · Annals of Oncology · 2011 · 141 citations

First-line Therapy, Urology, Phase Ii Trial +9

Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer

Neal Ready, Nina Karaseva, Alexander Luft et al. · Journal of Thoracic Oncology · 2011 · 92 citations · Full text

Oncology, Medicine, Clinical Trials +9

Analysis of amlodipine in human plasma by gas chromatography

Alan Beresford, P. V. Macrae, D. A. Stopher et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1987 · 80 citations

Medicine, Human Plasma, Analytical Chemistry +6

Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses.

Brian Wood, A. M. Monro · Sexually Transmitted Infections · 1975 · 77 citations · Full text

Medicinal Chemistry, Pharmacological Study, T. Vaginalis +13

A phase II, randomized trial using the small molecule tyrosine kinase inhibitor lapatinib as a first-line treatment in patients with FISH positive advanced or metastatic breast cancer

Henry Gómez, Miguel A. Chavez, Dinesh Chandra Doval et al. · Journal of Clinical Oncology · 2005 · 72 citations

Metastatic Breast Cancer, Oncology, Phase Ii +14